Plasma Kinetics of Tablet and Liquid Formulations of 6-mercaptopurine in Childhood Acute Lymphoblastic Leukemia

Trial Profile

Plasma Kinetics of Tablet and Liquid Formulations of 6-mercaptopurine in Childhood Acute Lymphoblastic Leukemia

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 May 2017

At a glance

  • Drugs Mercaptopurine (Primary)
  • Indications Acute lymphoblastic leukaemia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 10 May 2017 Planned number of patients changed from 30 to 16.
    • 10 May 2017 Planned End Date changed from 1 Mar 2017 to 1 Sep 2017.
    • 10 May 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top